Medicine
Emend 80 mg capsule
Emend 80 mg capsule is a prescription medicine containing Aprepitant for oral use, marketed by Merck Sharp & Dohme, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Once prepared, if suspension is not used immediately, store refrigerated…
Key facts
- Active ingredient (INN)
- Aprepitant
- Brand
- Emend
- Strength
- 80 mg
- Dosage form
- Capsule
- Route
- Oral
- Packs
- 2 capsules
- Marketing authorisation holder
- Merck Sharp & Dohme
- Manufacturer
- Merck Sharp & Dohme
- Origin register
- US FDA, United States
- Storage
- Once prepared, if suspension is not used immediately, store refrigerated [between 36°F-46°F (2°C-8°C)] for up to 72 hours prior to use. Store at 20-25°C (68-77°F). For Oral Suspension Store unopened pouch at 20-25°C (68-77°F), excursions permitted between 15-30°C (between 59-86°F). When ready to use, the mixture can be kept at room temperature [between 68°F-77°F (20°C-25°C)] for up to 3 hours.
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- A04AD12 Fosaprepitant
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 26 March 2003
- Identifiers
- DailyMed set ID 696f9e80-9cae-403b-de9e-078343ce4713NDC 0006-0461Application NDA021549
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 2 capsule in 1 dose pack | 0006-0461-02 | Merck Sharp & Dohme | 26 March 2003 |
| 2 capsule in 1 dose pack | 0006-0461-12 | Merck Sharp & Dohme | 26 March 2003 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Aprepitant 80 mg capsule.
Other strengths and forms of Aprepitant
Clinical summary
Aprepitant is a substance P/neurokinin-1 receptor antagonist. It is available as capsules, injectable emulsion and kits for oral and intravenous use. MedsAcross supplies Aprepitant for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about AprepitantFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- EMEND prescribing information (Merck Sharp & Dohme) · U.S. National Library of Medicine, DailyMed
- Emend: European public assessment report (EPAR) · European Medicines Agency
Need Emend 80 mg capsule for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.